SRC-3 Has a Role in Cancer Other Than as a Nuclear Receptor Coactivator
<p>Steroid receptor coactivator-3 (SRC-3), also known as AIB1, is a member of the p160 steroid receptor coactivator family. Since SRC-3 was found to be amplified in breast cancer in 1997, the role of SRC-3 in cancer has been broadly investigated. SRC-3 initially was identified as a transcripti...
Main Author: | Gang Ma, Yu Ren, Ke Wang, Jianjun He |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2011-01-01
|
Series: | International Journal of Biological Sciences |
Online Access: | http://www.biolsci.org/v07p0664.htm |
Similar Items
-
Implications of the Estrogen Receptor Coactivators SRC1 and SRC2 in the Biological Basis of Gender Incongruence
by: Karla del Valle Ramírez, Pre-doc, et al.
Published: (2021-06-01) -
SRC-2 Coactivator: a role in human metabolic evolution and disease
by: Bert W. O’Malley
Published: (2020-05-01) -
SRC-2 Is an Essential Coactivator for Orchestrating Metabolism and Circadian Rhythm
by: Erin Stashi, et al.
Published: (2014-02-01) -
Targeting Nuclear Receptor Coactivator SRC‐1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD‐L1
by: Yilin Hong, et al.
Published: (2024-09-01) -
Steroid receptor coactivator 3 (SRC-3/AIB1) is enriched and functional in mouse and human Tregs
by: Bryan C. Nikolai, et al.
Published: (2021-02-01)